4
Changes in Ownership
Merck & Co., Inc. Filed Acc 0001127602-21-028263
EVP, Chief Patient Officer sold 96,270 shares at $87.91 ($8,462,682)
- EVP, Chief Patient Officer acquired 96,270 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Gerberding Julie L. · EVP, Chief Patient Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-11-01 | Exercise or conversion : show line 1 in the form | +35,287 | 74,449.14 | D | ||
| 2021-11-01 | Exercise or conversion : show line 2 in the form | +30,175 | 104,624.14 | D | ||
| 2021-11-01 | Exercise or conversion : show line 3 in the form | +19,394 | 124,018.14 | D | ||
| 2021-11-01 | Exercise or conversion : show line 4 in the form | +11,414 | 135,432.14 | D | ||
| 2021-11-01 | Sale : show line 5 in the form | −96,270 | $87.91 | $8,462,682 | 39,162.14 | D |
| Open-market sales · 96,270 sh · avg $87.91 · $8,462,682 | ||||||
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-11-01 | Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) | −35,287 | 0 | D |
| 2021-11-01 | Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) | −30,175 | 0 | D |
| 2021-11-01 | Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) | −19,394 | 9,698 | D |
| 2021-11-01 | Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) | −11,414 | 22,831 | D |
Loading xslF345X03/form4.xml…